Review of Spinal Cord Stimulation in Peripheral Arterial Disease

Tiede, Jeffrey M; Huntoon, Marc A.

doi:10.1111/j.1094-7159.2004.04196.x

Cited by 18 publications

(7 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Multiple retrospective studies have demonstrated efficacy in terms of improved exercise, tolerance, reduced pain and limb salvage [9]. The selection criteria for this therapy in PVD include peripheral trans-cutaneous oxygen tension with those >20 mmHg (sitting) having the chance of adequate response [9,10].…”

Section: Peripheral Vascular Diseasementioning

confidence: 99%

Spinal Cord Stimulation What Do We Know?

Mahalle¹

2016

JACCOA

View full text Add to dashboard Cite

Neurochemical effects:There is no relation between SCS and opioid release, there is an increase dorsal horn GABA expression seen in animal model after SCS stimulation, levels of Substance P and serotonin are shown to be elevated by SCS. Studies have proven that excitatory amino acid release is suppressed by SCS via action on GABA-B receptors and intra-thecal adenosine as well baclofen may potentiate the effect of SCS. The net effect of these neurochemical effects reduces dorsal horn neuronal excitability [3].

show abstract

Section: Peripheral Vascular Diseasementioning

confidence: 99%

Spinal Cord Stimulation What Do We Know?

Mahalle¹

2016

JACCOA

View full text Add to dashboard Cite

show abstract

“…Electrical stimulation of the dorsal columns of the spinal cord, SCS, has become a well‐established treatment for a variety of chronic painful conditions including, but not limited to, chronic back pain radiating to the lower extremities (67–69), postlaminectomy pain syndrome (70–73), complex regional pain syndrome (73–76), peripheral vascular disease (78–81), and refractory angina pectoris (82–85). SCS is a technique involving electrical stimulation of carefully selected areas of the spinal cord, which processes the patient's pain complaint.…”

Section: Scs and Visceral Painmentioning

confidence: 99%

“…Spinal cord stimulation (SCS), a therapy that is efficacious for neuropathic pain states, and not nociceptive pain states, has been reserved, in the past, for pain of failed back surgery syndrome (3-5), complex regional pain syndrome (6)(7)(8)(9), angina (10)(11)(12), and peripheral vascular disease (13,14). Until recently, chronic visceral pain has been thought to be visceral somatic, nociceptive, in nature, and therefore, not amenable to treatment by SCS.…”

Section: Introductionmentioning

confidence: 99%

Spinal Cord Stimulation Modulates Visceral Nociception and Hyperalgesia via the Spinothalamic Tracts and the Postsynaptic Dorsal Column Pathways: A Literature Review and Hypothesis

Krames¹,

Foreman

2007

Neuromodulation: Technology at the Neural Interface

View full text Add to dashboard Cite

“…SCS provides a significant percentage of patients with sufficient pain relief to lead more active, less medicated lives (1). Since its first introduction in the late 1960s, SCS has become a well‐established treatment for a variety of chronic painful conditions including, but not limited to, chronic back pain radiating to the lower extremities (2–4), postlaminectomy pain syndrome (5–8), complex regional pain syndrome (9–12), peripheral vascular disease (13–16), and refractory angina pectoris (17–20).…”

Section: Introductionmentioning

confidence: 99%